AGC
ZURA icon

Angelo Gordon & Co’s Zura Bio ZURA Stock Holding History

Angelo Gordon & Co’s Portfolio ZURA Stock Details ZURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-22,500
Closed -$91.3K – 59
2024
Q3 		$91.3K Buy
+22,500
New +$84.1K 0.03% 54
2023
Q1 		– Sell
-286,694
Closed -$2.93M – 133
2022
Q4 		$2.93M Hold
286,694
– – 0.54% 27
2022
Q3 		$2.88M Hold
286,694
– – 0.52% 36
2022
Q2 		$2.85M Buy
286,694
+150,000
+110% +$1.49M 0.32% 39
2022
Q1 		$1.35M Hold
136,694
– – 0.15% 82
2021
Q4 		$1.35M Buy
+136,694
New +$1.35M 0.13% 94

Other funds holding ZURA

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Angelo Gordon & Co's ZURA Position: Q4 2024 in Review

Angelo Gordon & Co sold out of Zura Bio (ZURA) in Q4 2024, closing a stake of 22,500 shares — an estimated $91.3K sold.

Angelo Gordon & Co first reported a position in ZURA in Q4 2021 and held it in 6 quarters. The position peaked at $2.93M in Q4 2022. 87 funds tracked by Wall St. Rank hold ZURA as of Q4 2024.

  • Angelo Gordon & Co reported no remaining Zura Bio position as of Q4 2024 after selling out during the quarter.
  • Angelo Gordon & Co sold 22,500 Zura Bio shares in Q4 2024, an estimated $91.3K.
  • Angelo Gordon & Co first reported a position in Zura Bio in Q4 2021 and held it in 6 quarters.
  • Angelo Gordon & Co's Zura Bio position peaked at $2.93M in Q4 2022.
  • 87 funds tracked by Wall St. Rank held Zura Bio as of Q4 2024.

Based on Angelo Gordon & Co's 13F filing for Q4 2024, filed 14 Feb 2025.